| Product NDC: | 55154-3428 |
| Proprietary Name: | Comtan |
| Non Proprietary Name: | entacapone |
| Active Ingredient(s): | 200 mg/1 & nbsp; entacapone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-3428 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020796 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000101 |
| Package NDC: | 55154-3428-4 |
| Package Description: | 100 POUCH in 1 CARTON (55154-3428-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-3428-6) |
| NDC Code | 55154-3428-4 |
| Proprietary Name | Comtan |
| Package Description | 100 POUCH in 1 CARTON (55154-3428-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-3428-6) |
| Product NDC | 55154-3428 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | entacapone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20000101 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | ENTACAPONE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |